US Broker Ratings

DaVita Inc. (DVA) Stock Analysis: Evaluating the 11.63% Potential Upside in the Healthcare Sector

DaVita Inc. (DVA), a prominent player in the healthcare sector specializing in kidney dialysis services, is capturing investor attention with a market cap of $10.77 billion. Headquartered in Denver, Colorado,..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Navigating Growth with a 59.33% Return on Equity

In the dynamic landscape of healthcare diagnostics, IDEXX Laboratories, Inc. (NASDAQ: IDXX) stands out as a formidable player. With a market capitalization of $43.99 billion, IDEXX is a heavyweight in..

Doximity, Inc. (DOCS) Stock Analysis: A Healthcare Tech Leader with a Strong Growth Trajectory

Doximity, Inc. (NYSE: DOCS) continues to carve out a significant niche in the healthcare sector, positioning itself as a key player in health information services. With a market capitalization of..

HealthEquity, Inc. (HQY) Stock Analysis: Strong Analyst Ratings and 19% Potential Upside

HealthEquity, Inc. (NASDAQ: HQY), a leading player in the healthcare sector, stands out in the health information services industry with its robust offering of technology-enabled services platforms. With a market..

Revvity, Inc. (RVTY) Stock Analysis: Unpacking a 22.58% Upside Potential

Revvity, Inc. (NYSE: RVTY) is making waves in the healthcare sector, particularly within the diagnostics and research industry. With a robust market capitalization of $11.94 billion, this company is strategically..

Repligen Corporation (RGEN) Stock Analysis: Exploring a 42% Potential Upside in the Bioprocessing Sector

Repligen Corporation (NASDAQ: RGEN) has caught the attention of investors, particularly those interested in the healthcare sector. As a key player in the medical instruments and supplies industry, Repligen is..

McKesson Corporation (MCK) Stock Analysis: Navigating Healthcare with a $89.84 Billion Market Cap

McKesson Corporation (NYSE: MCK), a stalwart in the healthcare sector, continues to command investor attention with its robust market positioning and expansive operational footprint. As a leading player in the..

DexCom, Inc. (DXCM) Stock Analysis: A Promising 18.88% Potential Upside in the Healthcare Sector

DexCom, Inc. (NASDAQ: DXCM), a leader in the healthcare sector, particularly in medical devices, continues to stand out with its innovative continuous glucose monitoring (CGM) systems. With a market capitalization..

Moderna, Inc. (MRNA): Investor Outlook Reveals 56% Potential Upside Amidst Volatile Market Conditions

As a key player in the biotechnology sector, Moderna, Inc. (NASDAQ: MRNA) has garnered significant attention from investors, particularly with its innovative messenger RNA (mRNA) technology. Although its stock price..

The Cooper Companies, Inc. (COO) Investor Outlook: Assessing a 26.91% Potential Upside in the Healthcare Sector

The Cooper Companies, Inc. (NYSE: COO), a prominent player in the healthcare sector, offers considerable potential for investors seeking exposure to the medical instruments and supplies industry. With a market..

Verona Pharma plc (VRNA) Stock Analysis: A Biotech Gem with 30% Upside Potential

Verona Pharma plc (NASDAQ: VRNA), a promising player in the biotechnology industry, is capturing the attention of investors with its innovative approach to treating respiratory diseases. Headquartered in London, this..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A Strong Buy with Potential 71.78% Upside

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) continues to be a compelling choice for investors seeking opportunities within the biotechnology sector. Headquartered in Dublin, Ireland, Jazz specializes in identifying, developing, and commercializing..

Molina Healthcare Inc (MOH) Stock Analysis: Exploring a 50% Potential Upside

Investors eyeing the healthcare sector may want to take a closer look at Molina Healthcare Inc (NYSE: MOH), a stalwart in providing managed healthcare services under Medicaid and Medicare programs...

Waters Corporation (WAT): Investor Outlook Highlights 11% Potential Upside in Healthcare Sector

Waters Corporation (NYSE: WAT), a stalwart in the healthcare sector, has caught the attention of investors with its promising analytical workflow solutions, which are making significant impacts across the globe...

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Capitalizing on a 14.83% Potential Upside

Investors eyeing the healthcare sector have a promising candidate in GE HealthCare Technologies Inc. (NYSE: GEHC), currently trading at $76.07. With an impressive potential upside of 14.83%, the stock is..

Ascendis Pharma (ASND) Investor Outlook: Exploring a 32.83% Potential Upside

Ascendis Pharma A/S (NASDAQ: ASND) is drawing considerable attention in the biotechnology sector, not just for its innovative approach to addressing unmet medical needs, but also for the significant upside..

Labcorp Holdings Inc. (LH) Stock Analysis: Unveiling the Potential Upside in the Diagnostics Giant

Labcorp Holdings Inc. (NYSE: LH) stands as a formidable player in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $21.92 billion, Labcorp continues..

Centene Corporation (CNC) Stock Analysis: Exploring a 129.66% Potential Upside in Healthcare

Centene Corporation (NYSE: CNC) stands out in the healthcare sector, particularly within the healthcare plans industry. With a market capitalization of $16.58 billion, this U.S.-based company is a significant player..

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating a 2.25% Upside with Strategic Market Positioning

Henry Schein, Inc. (NASDAQ: HSIC), a stalwart in the healthcare sector, is a prominent player in the medical distribution industry. With a substantial market cap of $9.33 billion, the company..

Elevance Health, Inc. (ELV) Stock Analysis: Exploring a 43.96% Potential Upside

Elevance Health, Inc. (NYSE: ELV), a titan in the healthcare plans industry, presents a compelling case for investors seeking substantial upside potential. With a current market capitalization of approximately $78.59..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds